Stay updated on Cemiplimab in NSCLC: European Clinical Trial

Sign up to get notified when there's something new on the Cemiplimab in NSCLC: European Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cemiplimab in NSCLC: European Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    On 2026-02-20, Contacts/Locations and Study Status were added to the study record history. On 2026-02-18, the history now shows 20 entries.
    Difference
    0.4%
    Check dated 2026-02-25T08:39:49.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Added a new version entry: Revision: v3.4.2. Removed the funding-status notice and the prior Revision: v3.4.1 entry.
    Difference
    0.7%
    Check dated 2026-02-11T02:22:20.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding is now displayed. The footer revision tag has been updated from v3.4.0 to v3.4.1.
    Difference
    0.7%
    Check dated 2026-02-03T23:09:53.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The update adds UI enhancements to the record history, including a glossary toggle, green highlights for additions, red highlights for deletions, and a new revision label (v3.4.0). These changes do not modify the underlying study data.
    Difference
    0.9%
    Check dated 2026-01-27T22:58:56.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; this is a minor site version change with no impact on study data or core content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:56:31.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    A new history entry 'Revision: v3.3.3' was added and the footer now omits 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'.
    Difference
    0.2%
    Check dated 2025-12-23T10:13:12.000Z thumbnail image

Stay in the know with updates to Cemiplimab in NSCLC: European Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cemiplimab in NSCLC: European Clinical Trial page.